The FDA is about to decide which peptides could soon become widely
available in the U.S. Here’s what happens next.
-
The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be
legally compounded, potentially opening the door to broader use in
Americans.
7 minutes ago


In my 40 years working in design and innovation, alongside some of the most brilliant minds in the business, I have never seen innovation come out of a focus group. Let me put it more strongly: Focus groups kill innovation. That’s both because of what they do and what they don’t do.
ReplyDelete